HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kekäläinen, E. Articles by Arstila, T. P. Search for Related Content PubMed PubMed Citation Articles by Kekäläinen, E. Articles by Arstila, T. P. Pubmed/NCBI databases Genetics Home Reference

A Defect of Regulatory T Cells in Patients with Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy¹

Eliisa Kekäläinen^*, Heli Tuovinen^*, Joonas Joensuu^*, Mikhail Gylling^*, Rauli Franssila, Nora Pöntynen, Kimmo Talvensaari, Jaakko Perheentupa^¶, Aaro Miettinen^*,|| and T. Petteri Arstila^2,*,||

^* Department of Immunology and Department of Virology, Haartman Institute, University of Helsinki, Helsinki, Finland; Department of Molecular Medicine, National Public Health Institute, Helsinki, Finland; Blood Service, Finnish Red Cross, Helsinki, Finland; ^¶ Hospital for Children and Adolescents, Helsinki University Central Hospital, Helsinki, Finland; and ^|| Department of Immunology, Diagnostics Laboratory, Helsinki University Central Hospital, Helsinki, Finland

	Abstract

Top Abstract Introduction Materials and Methods Results Discussion Disclosures References

 
Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED), a monogenic recessive disease characterized by autoimmunity against multiple tissues, offers a unique possibility to study the breakdown of self-tolerance in humans. It is caused by mutations in the autoimmune regulator gene (AIRE), which encodes a transcriptional regulator. Work using Aire^–/– mice suggests that Aire induces ectopic expression of peripheral Ags and promotes their presentation in the thymus. We have explored reasons for the difference between the comparatively mild phenotype of Aire-deficient mice and human APECED patients. We provide evidence that, unlike in the Aire^–/– mice, in the patients a key mediator of active tolerance, the CD4⁺CD25⁺ regulatory T (Treg) cell subset is impaired. This was shown by significantly decreased expression of FOXP3 mRNA and protein, decreased function, and alterations in TCR repertoire. Also, in the normal human thymus a concentric accumulation of AIRE⁺ cells was seen around thymic Hassall’s corpuscles, suggesting that in the patients these cells may be involved in the observed Treg cell failure. In Aire^–/– mice the expression of FoxP3 was normal and even increased in target tissues in parallel with the lymphocyte infiltration process. Our results suggest that a Treg cell defect is involved in the pathogenesis of APECED and emphasize the importance of active tolerance mechanisms in preventing human autoimmunity.

	Introduction

Top Abstract Introduction Materials and Methods Results Discussion Disclosures References

 
Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED),³ or autoimmune polyendocrine syndrome I, is a rare, recessively inherited, monogenic disease enriched in populations such as the Finns, Sardinians, and Iranian Jews. It is characterized by autoimmune attack against multiple tissues, especially endocrine organs. In a Finnish cohort the final prevalence was estimated to be 88% for hypoparathyroidism, 84% for Addison’s disease, and 33% for diabetes (1). Other manifestations include gastric parietal cell atrophy, gonadal failure, and, in practically all patients, chronic mucocutaneous candidiasis. The onset of the disease usually takes place in early childhood, and most patients are symptomatic by the age of 10. The disease is caused by loss-of-function mutations in the autoimmune regulator gene (AIRE) (2, 3), structurally and functionally a transcriptional regulator that also contains a putative E3 ubiquitin ligase domain. AIRE is strongly expressed in thymic medullary epithelial cells (MECs) and at lower levels in many peripheral tissues, including spleen and lymph nodes (4, 5).

Because of its monogenic background, APECED offers a unique possibility to study the pathogenesis of organ-specific autoimmunity in humans. Work using Aire^–/– mice suggests that Aire up-regulates the expression of peripheral tissue-specific genes, including prominent autoantigens such as insulin, in the thymic MECs, a process termed ectopic transcription. In Aire^–/– mice the presentation of this set of peripheral Ags to developing T cells is disrupted, impairing negative selection and, in a transgenic model, allowing high-affinity autoreactive T cells to mature and migrate to the periphery (6, 7). More recently, it was shown that Aire also down-regulates many genes (8, 9), and appears to have direct effects on the Ag presentation machinery in the thymic MECs (10). Ubiquitin ligase activity by AIRE has also been reported (11), but these findings were subsequently challenged (12). The relative importance of these various putative functions of AIRE to the maintenance of tolerance is not known.

The Aire^–/– mice display signs of immunological dysregulation, T cell hyperreactivity, and perturbations of TCR repertoire, and by the age of 3 mo most of them have autoantibodies and lymphocyte infiltrates in multiple organs (6, 13, 14). However, in striking contrast to AIRE^–/– humans who invariably develop clinical autoimmunity, the Aire^–/– mice remain clinically healthy or in a few cases develop manifestations not seen in human APECED. These manifestations include an inflammation of lacrimal glands in one mouse strain (14) and inflammation of the exocrine pancreas in Aire^–/– NOD mice (15). Simultaneous expression of an Ag targeted to pancreatic islets and a transgenic TCR specific to it triggers diabetes in Aire^–/– mice, but thymic expression of the model Ag was shown to be Aire-independent (10). Thymic expression of the lacrimal gland autoantigen was also not affected by Aire-deficiency, and in both cases the pathogenetic mechanism leading to autoimmunity remains unclear. These discrepancies raise questions as to what extent the murine model really reflects the pathogenesis of APECED and what factors are behind the obvious clinical differences between AIRE^–/– humans and mice.

Another process potentially affected by loss-of-function mutations in AIRE is the development of CD4⁺CD25⁺ regulatory T (Treg) cells (16), which might be dependent on the thymic presentation of peripheral autoantigens. In mice, the deletion of these important mediators of active tolerance induces an organ-specific autoimmune syndrome that can be associated with endocrinopathies such as thyroiditis, adrenalitis, and diabetes (16). In humans, an impairment of Treg cells has recently been reported in autoimmune polyendocrine syndrome II (17), a syndrome of unknown and probably heterogeneous background, and Treg cells have also been explored in other autoimmune diseases (18). In Aire^–/– mice, Treg cells develop in normal numbers, possess a normal phenotype, and have been reported to function normally (7, 10, 14). In contrast, a cross between scurfy mice, which lack Treg cells, and Aire^–/– mice results in rapid lethality, showing that these two defects have a synergistic effect on murine autoimmunity (19).

In this study we show that in APECED patients the CD4⁺CD25⁺ Treg cell population is impaired. Our results extend the work done using Aire^–/– mice to humans and suggest that the failure of Treg cells is important for the progression to clinical autoimmunity.

	Materials and Methods

Top Abstract Introduction Materials and Methods Results Discussion Disclosures References

 
Patients

We studied 26 patients (14 women) with a mean age of 39.8 years (range 26–60) and 26 healthy controls (15 women) with a mean age of 40.2 years (range 23–65). APECED diagnosis was verified by sequencing the 14 exons and the exon-intron boundaries of the AIRE gene as described (20). The most common disease components were mucocutaneous candidiasis (26 of 26), Addison’s disease (22 of 26), hypoparathyroidism (19 of 26), hypogonadism (13 of 26), hypothyroidism (9 of 26), and diabetes (6 of 26); 21 were homozygous for the Finn-major mutation R257X. The patients received appropriate hormone replacement therapy of endocrine deficiencies at physiological doses, and in hypoparathyroidism normocalcemia was maintained with dihydrotachysterol and calcium. Because these treatments aim to restore normal hormonal levels, they should not have significant immunomodulatory effects. None of the patients received systemic immunosuppressive treatment at the time of the sampling. The HLA typing of our patients has been previously published (20). The HLA-matched control (Fig. 4) was identified among donors studied in 1996 for acute viral infection (21) and was healthy at the time of the sampling for the current study. None of the subjects was pregnant, had acute infections, or received vaccinations at the time of the sampling. All subjects gave written informed consent, and the study was approved by the ethical committee of the Helsinki University Hospital (Helsinki, Finland).

View larger version (76K): [in this window] [in a new window]   FIGURE 4. Fluorescence micrograph showing expression of AIRE in the human thymic medulla. Note the concentration of AIRE+ cells (arrows) in the periphery of Hassall’s corpuscles (H). Indirect immunofluorescence on cryostat sections using anti-human AIRE mAb and FITC-conjugated anti-mouse IgG, shown at x400 magnification.

Generation of C57BL/6 Aire^–/– mice by targeted disruption of the murine Aire gene has been described (13). The controls were parental, syngeneic wild-type (WT) mice. The mice were kept in a specific pathogen-free barrier at the National Public Health Institute, Helsinki, Finland, and sacrificed at the age of 5 or 6 mo. Perfused organs were frozen in liquid nitrogen and homogenized in TriPure reagent (Roche) using an Ultra-Turrax apparatus (Janke & Kunkel). RNA isolation was conducted using an RNeasy midi kit (Qiagen). The study was approved by the ethical committee of animal use at the National Public Health Institute and the University of Helsinki (Helsinki, Finland).

Cell isolation and culture

PBMC were isolated by Ficoll-Hypaque gradient centrifugation (Amersham Biosciences) and cryopreserved in 90% FCS and 10% DMSO. Normal CD25^high Treg cells were isolated from buffy coats obtained from healthy blood donors (Finnish Red Cross Blood Service, Helsinki, Finland) and used to test the ability of patient T cells to respond to Treg cell-mediated signals. Cell sorting and RNA extraction were performed on freshly isolated cells. PBMC were cultured in duplicate in a 96-well plate for 5 days at 2 x 10⁵ cells per 200 µl of RPMI medium (Invitrogen Life Technologies) supplemented with 10% heat-inactivated human AB serum (Finnish Red Cross Blood Service), 20 mM HEPES, 2 mM L-glutamine, 50 µM 2-ME, 100 µg/ml streptomycin, and 100 U/ml penicillin (supplements from Sigma-Aldrich). The PBMC were pulsed for the last 6 h with [³H]thymidine (1 µCi/well; Amersham Biosciences), harvested with a Skatron harvester, and analyzed with a liquid scintillation counter (Wallac). Background in nonstimulated wells was subtracted to obtain the specific proliferative response. Anti-CD3 mAb (50 µg/ml) was immobilized by incubating it in the culture well for 1 h, after which unbound mAb was washed away. Heat-killed Candida albicans (2.5 µg/ml) was prepared by incubating yeast cells in PBS at 56°C for 30 min. PHA (Sigma-Aldrich) was used at 5 µg/ml and human insulin (Orion Pharma) at 10, 2, or 0.4 µg/ml.

Cell separation, flow cytometry, and immunohistochemistry

Cell sorting was done with a FACStar sorter and flow cytometry with a FACScan instrument (BD Biosciences). Anti-FOXP3 mAb (clone 150) was a gift from A. Banham (Oxford University, Oxford, U.K.), anti-AIRE mAb was from P. Peterson (University of Tartu, Tartu, Estonia), and PE-labeled anti-FOXP3 mAb was purchased from eBioscience. All other mAbs were purchased from BD Biosciences. For intracellular detection of FOXP3, the cells were permeabilized by a commercially available reagent (eBioscience) and then stained as described by Roncador et al. (22). Anti-CD25 mAb-coated Dynabeads (Dynal) were used to isolate CD25^high cells for cell culture experiments. The captured cells were detached by overnight incubation at 37°C. The purity was determined with flow cytometry and typically ranged between 70 and 90%. Thymic tissue was obtained from children undergoing cardiac surgery. The removed tissue was immediately frozen in liquid nitrogen or fixed in formalin. For immunofluorescence, acetone-fixed (at –20°C for 20 min), 5-µm cryostat sections were stained with either goat anti-human AIRE (Santa Cruz Biotechnology) or anti-human AIRE mAb followed by appropriate FITC-labeled second-step reagents. For immunohistochemistry, 5-µm sections of the paraffin-embedded, formalin-fixed tissues were dewaxed, heated by microwave oven in a buffer containing 1 mM EDTA in 10 mM Tris-HCl (pH 9.0) for 10 min for Ag retrieval, and stained with the monoclonal anti-AIRE Abs and goat anti-mouse IgG Abs conjugated with HRP using the EnVision+ protocol (DakoCytomation). The densities of the AIRE⁺ cells in the thymic medulla at or in the near vicinity of Hassall’s corpuscles and at more remote medullary areas were estimated in sections stained by the indirect immunofluorescence or immunohistochemistry techniques. An Olympus BX50 microscope equipped with an Orca IIIm charge-coupled device camera (Hamamatsu Photonics) was used for analysis.

PCR and TCR repertoire analysis

Total RNA was extracted with the RNeasy kit (Qiagen) and cDNA synthesized with avian myeloblastosis virus reverse transcriptase (Finnzymes). A semiquantitative PCR using housekeeping gene primers was performed to test the quality of the cDNA, with no significant differences between the groups. Real-time PCR detection of human or murine FOXP3 was done by using TaqMan Universal PCR master mix and commercially available, intron-spanning primers with FAM-labeled TaqMan minor groove binder probes, all purchased from Applied Biosystems. Because the assay for murine TCR C (primers 5'-GTCTGGTTGCTCCAGGCAAT-3' and 5'-TGACAAAACTGTGCTGGACATG-3' and probe 6'-AGCTATGGATTCCAAGAGCAATGGGGC-3') was not designed to span an intron, the mouse RNA was treated with DNase I (Sigma-Aldrich) and the absence of genomic DNA was verified by real-time PCR. The reactions were run in duplicate with an ABI 7900HT instrument (Applied Biosystems).

TCR repertoire analysis was performed as described (23). A set of 24 V-specific primers was used with a C-specific primer to amplify the total V repertoire, followed by a runoff reaction with an internal FAM-labeled C primer. All primers were synthesized by Sigma-Genosys, and AmpliTaq Gold enzyme was used for the PCR (Applied Biosystems). The amplification products were separated and visualized on a 9% acrylamide gel by using an ABI377 sequencer (Applied Biosystems). The repertoire of cord blood T cells represents the mean of 11 samples and has been previously described (24). For quantitation of similarity, we adapted the method published by Gorochov et al. (25). The areas of all the individual peaks in a V-C profile were expressed as a percentage of the combined area of that profile and compared with corresponding values of the cord blood TCR repertoire. The absolute values of the differences of all the individual peaks were summed, divided by two, and subtracted from 100, giving the similarity of the analyzed repertoire with the cord blood repertoire. A fully overlapping repertoire would give a value of 100, whereas a value of 0 would signify a totally different and nonoverlapping repertoire.

DNA was isolated using a QIAamp blood kit (Qiagen), and the amount of TCR excision circles was estimated by a quantitative PCR-ELISA, as described (26).

Statistical analysis

Error bars indicate SD. p values were calculated with a two-tailed Student t test and correlations were determined using Pearson’s correlation coefficient, with a limit of p < 0.05 for significance. For p values of AIRE⁺ cell densities in the different areas of the thymus, the Mann-Whitney U test was used.

	Results

Top Abstract Introduction Materials and Methods Results Discussion Disclosures References

 
Suppressive function of CD4⁺CD25⁺ cells in APECED patients

In humans, CD25⁺ Treg cells form a subset of roughly 5% of all CD4⁺ T cells and have been reported to be those with the highest expression of CD25 (hereafter designated CD25^high) (22, 27, 28). There was no difference in the frequency of CD25^high cells or the intensity of CD25 expression between APECED patients and controls (Table I). Therefore, with a coculture assay of isolated CD25^high and CD25^– cells we tested whether a functional impairment could be observed in the CD25^high Treg cells of the patients. Unfractionated cells from patients and controls proliferated vigorously and equally well in response to polyclonal stimulation with immobilized anti-CD3 mAb or PHA. In controls at a ratio of one CD25^high cell per three CD25^– cells this response was diminished by 20–50%, whereas at the ratio of 1:1 it decreased by 85–95% (Fig. 1). In contrast, coculture with CD25^high cells from the patients failed to significantly suppress the response of CD25^– cells to anti-CD3 mAb or PHA, consistent with a diminished suppressive capacity of their CD25^high population. However, CD25^high cells from both patients and controls were equally capable of suppressing the response to C. albicans, possibly because this is an Ag-specific response and therefore more limited than the polyclonal stimulation by PHA or anti-CD3 mAb. This result also showed that T cells from the APECED patients were not intrinsically resistant to suppressive signals from Treg cells. To further exclude this possibility, we isolated CD25^high Treg cells from healthy blood donors and cultured them together with T cells from APECED patients or controls at a ratio of one per one cell. Treg cells obtained from a healthy donor were able to suppress anti-CD3-induced proliferative responses equally efficiently in patients and controls (a decrease of 79.5 ± 12.2 and 73.8 ± 23.2%, respectively). An attempt to test the effect of CD25^high cells on responses against insulin, a peripheral Ag up-regulated by Aire in the murine thymus (6), was unsuccessful because insulin did not elicit a measurable proliferative response in any of the controls or patients.

View larger version (12K): [in this window] [in a new window]   FIGURE 1. Suppression of proliferative responses by CD25high cells. CD25high cells were isolated using magnetic beads and cultured with CD25– cells at the indicated ratios. p values for the difference between patients (•; n = 6) and controls (; n = 6) at the ratio of one CD25high cell per one CD25– cell are shown.

The results described above suggested that, despite a normal frequency of CD25^high cells, the Treg cell population in the patients was impaired. However, because CD25 is not expressed exclusively by Treg cells, it was important to exclude the possibility that an increased frequency of activated T cells in the patients could be responsible for the findings. There was no significant difference in the expression of HLA-DR or CD62L, markers associated with activation status, on CD3⁺ cells from the patients or controls. We then determined the expression of these markers in the CD25^high population and also that of CD45RO, recently reported to differentiate CD25⁺ Treg cells from nonregulatory CD25⁺ T cells (28). Again, no significant differences between the patients and controls were observed (Table I).

Next, we analyzed the Candida-specific proliferative response of CD25^high and CD25^– cells. Both patients and controls had an equally strong response to heat-killed C. albicans, reflecting the ubiquitous nature of this opportunistic pathogen. Because the patients had a chronic candidiasis, we reasoned that if the CD25^high population in the patients consisted of activated cells, a significant fraction of the CD25^high cells should be Candida-specific. In this case, depletion of CD25^high cells would result in a decreased response to Candida, but no such diminution of the response was observed (Table I). Depletion of CD25^high cells had also no significant effect on polyclonal, anti-CD3-induced responses. Finally, we determined the TCR excision circle content of PBL from patients and controls. These extrachromosomal circles are not replicated along the chromosomal DNA, leading to their dilution during mitosis. Although variation was high in both groups, the TCR excision circle level in the patients was not significantly different from that of the controls (data not shown), indicating that the circulating cells had a roughly similar proliferative history.

Expression of FOXP3 in APECED patients

The most reliable Treg cell marker is FOXP3, a transcription factor expressed by >95% of human CD25^high cells and closely associated with both the development and suppressive function of Treg cells (22, 28, 29). PBMC from the controls had 2-fold more FOXP3 mRNA than PBMC from the patients (Fig. 2A). We then sorted the CD25^high cells from six randomly chosen patients and six controls. As expected, FOXP3 mRNA was expressed at a much higher level in the CD25^high cells than in the total PBMC in both patients and controls. However, CD25^high cells from the controls expressed, on the average, four times more FOXP3 than CD25^high cells from the patients (Fig. 2B). Thus, the patients expressed consistently less FOXP3 mRNA, both in the CD25^high subset and in the total T cell population.

View larger version (49K): [in this window] [in a new window]   FIGURE 2. Analysis of FOXP3 mRNA and protein expression in the controls and patients. A, Relative expression of FOXP3 mRNA in PBMC. B, Relative expression of FOXP3 mRNA in CD25high cells. C, Frequency of FOXP3+ PBMC. D, Comparison of the FOXP3 protein content in the CD25high cells of a patient and a control. E and F, Frequency and mean fluorescence intensity (MFI) of FOXP3 expression in gated CD4+ cells (E) and CD45RA– (F) cells. In A and B the results were normalized against -actin and quantified by comparing the normalized values to serial dilutions of two cDNA samples. The patients and controls shown in E are different from those shown in F.

TCR repertoire of CD25^high cells in APECED patients

To obtain a more detailed view of the Treg cell defect in the patients, we analyzed the TCR -chain repertoire of CD25^high cells. It has been reported that Treg cells express a highly diverse TCR repertoire (30), a finding that our analysis of healthy controls confirmed (data not shown). Because HLA type can influence TCR V gene usage and distort results obtained from small numbers of cells, we first searched among a set of HLA-typed donors for a healthy control matched at the HLA class II locus with any of our patients. One such match was identified, a female (58 years old) with a shared class II HLA-type DRB1*0301; 01, DQA1*0101; 0501, DQB1*0201; 0501, DPB1*0401. The patient was a 26-year-old female, homozygous for R257X mutation in the AIRE gene, with candidiasis and parathyroid, adrenal, and ovarian failure as disease manifestations.

To obtain a reliable comparison, we sorted the same number of CD25^high cells from the patient and the control and also adjusted the samples by quantitative -actin amplification. The total TCR -chain repertoire was amplified by using 24 different V -specific primers followed by electrophoretic analysis. This method typically produces 6–10 bands for each V-gene, corresponding to in-frame rearrangements with different CDR3 lengths, and allows both a global view of the repertoire as well as sensitive detection of subtle changes (23). Reflecting the polyclonal nature of the Treg cell repertoire, the CD25^high cells expressed most V genes even though the sample size was only 50,000 sorted cells. However, when the patient was compared with the control a significant difference in the TCR diversity was observed. In the control the CDR3 length distribution revealed clonal expansions in most V genes, while in the patient the repertoire was much less skewed (Fig. 3A). The average number of different CDR3 lengths within individual V genes was likewise significantly higher in the patient (Fig. 3B). Finally, a comparison of CD25^high cells from the APECED patient and the control to an average naive repertoire derived from 11 cord blood samples showed that the CD25^high cell repertoire of the APECED patient was significantly closer to the naive repertoire than the repertoire of the control (Fig. 3C).

View larger version (18K): [in this window] [in a new window]   FIGURE 3. Analysis of TCR -chain repertoire of CD25high cells. A, Comparison of four V profiles from an HLA class II-matched patient and control, B and C, the average number of CDR3 lengths (B) and the similarity, on a scale of 0–100, of the repertoire of CD25high cells to an average naive, polyclonal repertoire (C). D, Similarity of the repertoire of CD25high cells to a naive repertoire in HLA-nonmatched patients and controls (n = 4). V genes not expressed in the sample were excluded. In A the most diverse rearrangements in the healthy control are shown; note the deviations from a polyclonal, Gaussian distribution in all four V genes.

Expression of AIRE in human thymus

The expression of AIRE in the thymic MECs is believed to play a role in the negative selection of autoreactive T cells (4, 5, 6, 7), but another structure, the epithelial Hassall’s corpuscle, seems to be important in the positive selection of human CD25⁺ Treg cells (31). We therefore examined the relationship of AIRE⁺ cells and Hassall’s corpuscles in four different thymic tissues. Thymic tissues stained by immunofluorescence or immunohistochemical techniques with a monoclonal anti-human AIRE showed AIRE⁺ cells dispersed within the thymic medulla and at the margins of Hassall’s corpuscles, although the corpuscles themselves were mostly AIRE^– (Fig. 4). The median density of AIRE⁺ cells at or in the near vicinity of Hassall’s corpuscles was 68.4 cells/mm² (median range, 19.5–146.5), whereas the mean density in the more remote medullary areas was 26.1 cells/mm² (median range, 13.0–78.1; p = 0.003). In total, 12 visual fields (3.6 mm²; magnification, x200) were counted. Similar results were also obtained by using polyclonal anti-AIRE Abs (data not shown).

Expression of FoxP3 in Aire^–/– mice

It has been reported that in Aire^–/– mice CD4⁺CD25⁺ Treg cells develop in normal numbers and also function normally. To test whether a failure of Treg cell development takes place in the mouse strain mimicking the most common AIRE mutation (R257X; see Ref. 13), we analyzed FoxP3 mRNA levels in six Aire^–/– and six WT mice but found no significant difference in either the thymus or the spleen (data not shown). Salivary glands, one of the target tissues of the autoimmune process, contained more T cells in the Aire^–/– mice than in the WT mice as shown by a higher level of TCR C mRNA. In addition to these infiltrating T cells, the salivary glands from the Aire^–/– mice also had a significantly higher level of FoxP3 mRNA than salivary glands from the WT mice. Importantly, there was a highly significant correlation between the level of TCR C and FoxP3 expression (Fig. 5), indicating that the amount of FoxP3-expressing Treg cells increased in parallel with the infiltration process. Together with the previously published reports (7, 10, 14), these data indicate that there is no Treg cell defect comparable to that observed in APECED patients in the Aire^–/– mice, either systemically or locally in the target organs.

View larger version (8K): [in this window] [in a new window]   FIGURE 5. Expression of FoxP3 and TCR C in salivary glands of Aire–/– and WT mice. Expression levels were determined by real-time semiquantitative PCR of cDNA synthesized from total tissue RNA. The results were normalized against GAPDH and quantified by comparing to serial dilutions of two cDNA samples. The p value for the correlation between the expression of FoxP3 and TCR C in individual animals is shown.

	Discussion

Top Abstract Introduction Materials and Methods Results Discussion Disclosures References

When studying abnormalities of the immune system, it can be difficult to separate the primary causative events from the secondary consequences of immunopathology. This is especially true of human disease, where the onset of the autoimmune process usually precedes clinical symptoms, often by several years. We therefore took care to exclude the possibility that the observed differences between patients and controls could be due to an increased frequency of activated CD25⁺ T cells diluting the Treg cells. Several lines of evidence make this unlikely. There was no significant difference in the expression pattern of CD25 or in the expression of several activation markers, either in the total T cell population or in the CD25^high subset. This included CD45RO, a marker recently shown to distinguish regulatory from nonregulatory CD25⁺ cells in humans (28). The CD25^high population was not enriched in Candida-specific T cells, and the proliferative history of circulating T cells was similar in both patients and controls. Importantly, even though FOXP3 levels were lower in the patients, intracellular FOXP3 staining showed that the CD25^high population in the patients could not be divided into FOXP3^– cells and FOXP3⁺ Treg cells. This result indicates that the CD25^high cells of the patients were not measurably diluted by FOXP3^–-activated cells that would be responsible for the observed differences. It therefore seems that the disease process in APECED, as in several other organ-specific autoimmune diseases, is restricted to the affected tissues and does not induce measurable systemic T cell activation (33).

How then does the lack of functional AIRE lead to a defect of Treg cells? Relatively little is known about the development of Treg cells in humans, but in transgenic mice the expression of an agonist peptide on thymic epithelium is sufficient for Treg cell generation (34). Other data indicate that thymic development of FOXP3⁺ Treg cells is driven by self-Ags, and the mature population is autoreactive (16, 29, 35, 36). The selecting Ags are thus likely to be the same ones that mediate negative selection of clones with a higher affinity. Because loss-of-function mutations in AIRE affect ectopic transcription in the thymus, at least in the mouse, the Treg cell defect in APECED patients might be a consequence of the lack of peripheral Ags in the thymus. Immature thymocytes with an intermediate affinity TCR would normally be positively selected to form the natural, Ag-specific Treg cell population but, in the absence of AIRE, do not receive a TCR-mediated signal and fail to mature. In this case the resultant Treg cell defect would be restricted to Ags regulated by AIRE, which might explain the organ specificity of the human APECED.

However, given the recently revealed complexities of the Aire-deficient phenotype in mice, the failure of ectopic transcription is by no means the only possibility. If AIRE-deficiency indeed leads to a generalized defect of thymic Ag presentation (10), the development of Treg cells could also be more generally affected. The failure of Treg cells isolated from APECED patients to suppress polyclonal responses induced by anti-CD3 mAb or PHA might well be an argument in favor of such a systemic defect not limited to any specific AIRE-controlled peripheral Ag. The TCR repertoire of Treg cells from patients was also quite different from that of the controls and in many ways less focused and closer to a naive repertoire. This marked difference in the clonal distribution of Treg cells in patients and controls suggests a wider aberration, because an Ag-specific failure would be expected to manifest as narrow holes in an otherwise normal repertoire. Also, AIRE is expressed in peripheral tissues (4, 5), albeit at lower levels than in the thymus, and it may be associated with the differentiation of dendritic cells or their interaction with T cells (37, 38, 39). Disruption of dendritic cell function could well contribute to the kind of defect observed in our analysis of TCR repertoire. The abnormal Treg cell repertoire in APECED patients might therefore reflect the failure of both thymic selection and peripheral activation and expansion of Treg cells.

It was recently shown that the epithelial cells at the margins of the Hassall’s corpuscles produce thymic stromal lymphopoietin, which induces the generation of CD11c⁺ dendritic cells (31). These dendritic cells, in turn, support the development of human Treg cells and, in the normal human thymus, CD25⁺ Treg cells are located exclusively in the medullary areas surrounding Hassall’s corpuscles, colocalizing with the thymic stromal lymphopoietin-producing epithelial cells. Interestingly, AIRE⁺ cells were also found around the Hassall’s corpuscles, so the loss of AIRE function at this location may be behind the observed broad Treg cell impairment in APECED patients. Especially suggestive is the fact that Hassall’s corpuscles are abundant in humans but rare in the murine thymus (40). Although it is indirect evidence, this interspecies difference might provide a mechanistic explanation for the difference in Treg cell function and clinical phenotype in Aire-deficient mice and APECED patients.

In conclusion, our data indicate that Treg cell failure is an important factor in the development of APECED. The presence of autoreactive T cells in healthy individuals is a well-known phenomenon and in itself is insufficient to break tolerance (41). Even in the absence of AIRE-regulated ectopic transcription of peripheral Ags in the thymus and a concomitant impairment of negative selection, no disease occurs without a defect in the Treg cell population. The well-defined monogenic background of APECED and analysis of the functional properties of the AIRE protein will help in further elucidating the balance between autoreactivity and immunoregulation in human autoimmunity.

	Acknowledgments

 
We thank M. Schoultz and R. Väisänen for technical assistance, A. Banham and P. Peterson for the gift of mAb, and S. Meri and I. Ulmanen for comments on the manuscript.

	Disclosures

Top Abstract Introduction Materials and Methods Results Discussion Disclosures References

 
The authors have no financial conflict of interest.

	Footnotes

 
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

¹ This work was supported by the Academy of Finland, the Ahokas Foundation, the Helsinki University Science Foundation, research funds of the Helsinki University Central Hospital, the Sigrid Juselius Foundation, the Päivikki and Sakari Sohlberg Foundation, the Maud Kuistila Foundation, Finska Läkaresällskapet, and the European Union’s Sixth Framework Programme (European Association of Plastic Surgeons) Project LSHM-CT-2005-005223.

² Address correspondence and reprint requests to Dr. T. Petteri Arstila, Haartman Institute, Department of Immunology, PB21, 00014 University of Helsinki, Finland. E-mail address: petteri.arstila{at}helsinki.fi

³ Abbreviations used in this paper: APECED, autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy; AIRE, autoimmune regulator; Treg, regulatory T; MEC, thymic medullary epithelial cell; WT, wild type.

Received for publication April 19, 2006. Accepted for publication October 26, 2006.

	References

Top Abstract Introduction Materials and Methods Results Discussion Disclosures References

 

1. Perheentupa, J.. 2006. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J. Clin. Endocrinol. Metab. 91: 2843-2850. [Abstract/Free Full Text]
2. Finnish-German APECED Consortium 1997. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nat. Genet. 17: 399-403. [Medline]
3. Nagamine, K., P. Peterson, H. S. Scott, J. Kudoh, S. Minoshima, J. Heino, K. J. Krohn, M. D. Lalioti, P. E. Mullis, S. E. Antonarakis, et al 1997. Positional cloning of the APECED gene. Nat. Genet. 17: 393-398. [Medline]
4. Björses, P., M. Pelto-Huikko, J. Kaukonen, J. Aaltonen, L. Peltonen, I. Ulmanen. 1999. Localization of the APECED protein in distinct nuclear structures. Hum. Mol. Genet. 8: 259-266. [Abstract/Free Full Text]
5. Heino, M., P. Peterson, J. Kudoh, K. Nagamine, A. Lagerstedt, V. Ovod, A. Ranki, I. Rantala, M. Nieminen, J. Tuukkanen, et al 1999. Autoimmune regulator is expressed in the cells regulating immune tolerance in thymus medulla. Biochem. Biophys. Res. Commun. 257: 821-825. [Medline]
6. Anderson, M. S., E. S. Venanzi, L. Klein, Z. Chen, S. P. Berzins, S. J. Turley, H. von Boehmer, R. Bronson, A. Dierich, C. Benoist, et al 2003. Projection of an immunological self shadow within the thymus by the aire protein. Science 298: 1395-1401.
7. Liston, A., S. Lesage, J. Wilson, L. Peltonen, C. Goodnow. 2003. Aire regulates negative selection of organ-specific T cells. Nat. Immunol. 4: 350-354. [Medline]
8. Derbinski, J., J. Gabler, B. Brors, S. Tierling, S. Jonnakuty, M. Hergenhahn, L. Peltonen, J. Walter, B. Kyewski. 2005. Promiscuous gene expression in thymic epithelial cells is regulated at multiple levels. J. Exp. Med. 202: 33-45. [Abstract/Free Full Text]
9. Johnnidis, J. B., E. S. Venanzi, D. J. Taxman, J. P. Ting, C. O. Benoist, D. J. Mathis. 2005. Chromosomal clustering of genes controlled by the aire transcription factor. Proc. Natl. Acad. Sci. USA 102: 7233-7238. [Abstract/Free Full Text]
10. Anderson, M. S., E. S. Venanzi, Z. Chen, S. P. Berzins, C. Benoist, D. Mathis. 2005. The cellular mechanism of Aire control of T cell tolerance. Immunity 23: 227-239. [Medline]
11. Uchida, D., S. Hatakeyama, A. Matsushima, H. Han, S. Ishido, H. Hotta, J. Kudoh, N. Shimizu, V. Doucas, K. I. Nakayama, et al 2004. AIRE functions as an E3 ubiquitin ligase. J. Exp. Med. 199: 167-172. [Abstract/Free Full Text]
12. Bottomley, M. J., G. Stier, D. Pennacchini, G. Legube, B. Simon, A. Akhtar, M. Sattler, G. Musco. 2005. NMR structure of the first PHD finger of autoimmune regulator protein (AIRE1). Insights into autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) disease. J. Biol. Chem. 280: 11505-11512. [Abstract/Free Full Text]
13. Ramsey, C., O. Winqvist, L. Puhakka, M. Halonen, A. Moro, O. Kämpe, P. Eskelin, M. Pelto-Huikko, L. Peltonen. 2002. Aire deficient mice develop multiple features of APECED phenotype and show altered immune response. Hum. Mol. Genet. 11: 397-409. [Abstract/Free Full Text]
14. Kuroda, N., T. Mitani, N. Takeda, N. Ishimaru, R. Arakaki, Y. Hayashi, Y. Bando, K. Izumi, T. Takahashi, T. Nomura, et al 2005. Development of autoimmunity against transcriptionally unrepressed target antigen in the thymus of Aire-deficient mice. J. Immunol. 174: 1862-1870. [Abstract/Free Full Text]
15. Jiang, W., M. S. Anderson, R. Bronson, D. Mathis, C. Benoist. 2005. Modifier loci condition autoimmunity provoked by Aire deficiency. J. Exp. Med. 202: 805-815. [Abstract/Free Full Text]
16. Sakaguchi, S.. 2004. Naturally arising CD4⁺ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22: 531-562. [Medline]
17. Kriegel, M. A., T. Lohmann, C. Gabler, N. Blank, J. R. Kalden, H.-M. Lorenz. 2004. Defective suppressor function of human CD4⁺CD25⁺ regulatory T cells in autoimmune polyglandular syndrome type II. J. Exp. Med. 199: 1285-1291. [Abstract/Free Full Text]
18. Wraith, D. C., K. S. Nicolson, N. T. Whitley. 2004. Regulatory CD4⁺ T cells and the control of autoimmune disease. Curr. Opin. Immunol. 16: 695-701. [Medline]
19. Chen, Z., C. Benoist, D. Mathis. 2005. How defects in central tolerance impinge on a deficiency in regulatory T cells. Proc. Natl. Acad. Sci. USA 102: 14735-14740. [Abstract/Free Full Text]
20. Halonen, M., P. Eskelin, A. G. Myhre, J. Perheentupa, E. S. Husebye, O. Kampe, F. Rorsman, L. Peltonen, I. Ulmanen, J. Partanen. 2002. AIRE mutations and human leukocyte antigen genotypes as determinants of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy phenotype. J. Clin. Endocrinol. Metab. 87: 2568-2574. [Abstract/Free Full Text]
21. Mustonen, J., J. Partanen, M. Kanerva, K. Pietila, O. Vapalahti, A. Pasternack, A. Vaheri. 1996. Genetic susceptibility to severe course of nephropathia epidemica caused by Puumala hantavirus. Kidney Int. 49: 217-221. [Medline]
22. Roncador, G., P. J. Brown, L. Maestre, S. Hue, J. L. Martinez-Torrecuadrada, K. L. Ling, S. Pratap, C. Toms, B. C. Fox, V. Cerundolo, et al 2005. Analysis of FOXP3 protein expression in human CD4⁺CD25⁺ regulatory T cells at the single-cell level. Eur. J. Immunol. 35: 1681-1691. [Medline]
23. Pannetier, C., J. Even, P. Kourilsky. 1995. T-cell repertoire diversity and clonal expansions in normal and clinical samples. Immunol. Today. 16: 176-181. [Medline]
24. Talvensaari, K., E. Clave, C. Douay, C. Rabian, L. Garderet, M. Busson, F. Garnier, D. Douek, E. Gluckman, D. Charron, et al 2002. A broad T-cell repertoire diversity and an efficient thymic function indicate a favorable long-term immune reconstitution after cord blood stem cell transplantation. Blood 99: 1458-1464. [Abstract/Free Full Text]
25. Gorochov, G., A. U. Neumann, A. Kereveur, C. Parizot, T. Li, C. Katlama, M. Karmochkine, G. Raguin, B. Autran, P. Debre. 1998. Perturbation of CD4⁺ and CD8⁺ T-cell repertoires during progression to AIDS and regulation of the CD4⁺ repertoire during antiviral therapy. Nat. Med. 4: 215-221. [Medline]
26. Al-Harthi, L., G. Marchetti, C. M. Steffen, J.-F. Pulin, R.-P. Sekaly, A. Landay. 2000. Detection of T cell receptor circles (TRECs) as biomarkers for de novo T cell synthesis using a quantitative polymerase chain reaction-enzyme linked immunosorbent assay (PCR-ELISA). J. Immunol. Meth. 237: 187-197. [Medline]
27. Baecher-Allan, C., J. A. Brown, G. J. Freeman, D. A. Hafler. 2001. CD4⁺CD25high regulatory cells in human peripheral blood. J. Immunol. 167: 1245-1253. [Abstract/Free Full Text]
28. Yagi, H., T. Nomura, K. Nakamura, S. Yamazaki, T. Kitawaki, S. Hori, M. Maeda, M. Onodera, T. Uchiyama, S. Fujii, et al 2004. Crucial role of FOXP3 in the development and function of human CD25⁺CD4⁺ regulatory T cells. Int. Immunol. 16: 1643-1656. [Abstract/Free Full Text]
29. Fontenot, J. D., A. Y. Rudensky. 2005. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat. Immunol. 6: 331-337. [Medline]
30. Kasow, K. A., X. Chen, J. Knowles, D. Wichlan, R. Handgretinger, J. M. Riberdy. 2004. Human CD4⁺CD25⁺ regulatory T cells share equally complex and comparable repertoires with CD4⁺CD25^– counterparts. J. Immunol. 172: 6123-6128. [Abstract/Free Full Text]
31. Watanabe, N., Y. H. Wang, H. K. Lee, T. Ito, Y. H. Wang, W. Cao, Y. J. Liu. 2005. Hassall’s corpuscles instruct dendritic cells to induce CD4⁺CD25⁺ regulatory T cells in human thymus. Nature 436: 1181-1185. [Medline]
32. Herman, A. E., G. J. Freeman, D. Mathis, C. Benoist. 2004. CD4⁺CD25⁺ T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion. J. Exp. Med. 199: 1479-1489. [Abstract/Free Full Text]
33. G. S. Eisenbarth, ed. Endocrine and Organ Specific Autoimmunity 1999271 Landes Bioscience, Austin, TX.
34. Jordan, M. S., A. Boesteanu, A. J. Reed, A. L. Petrone, A. E. Holenbeck, M. A. Lerman, A. Naji, A. J. Caton. 2001. Thymic selection of CD4⁺CD25⁺ regulatory T cells induced by an agonist self-peptide. Nat. Immunol. 2: 301-306. [Medline]
35. Hsieh, C. S., Y. Liang, A. J. Tyznik, S. G. Self, D. Liggitt, A. Y. Rudensky. 2004. Recognition of the peripheral self by naturally arising CD25⁺CD4⁺ T cell receptors. Immunity 21: 267-277. [Medline]
36. Romagnoli, P., D. Hudrisier, J. P. M. van Meerwijk. 2002. Preferential recognition of self antigens despite normal thymic deletion of CD4⁺CD25⁺ regulatory T cells. J. Immunol. 168: 1644-1648. [Abstract/Free Full Text]
37. Sillanpaa, N., C. G. Magureanu, A. Murumagi, A. Reinikainen, A. West, A. Manninen, M. Lahti, A. Ranki, K. Saksela, K. Krohn, et al 2004. Autoimmune regulator induced changes in the gene expression profile of human monocyte-dendritic cell-lineage. Mol. Immunol. 41: 1185-1198. [Medline]
38. Ramsey, C., S. Hassler, P. Marits, O. Kampe, C. D. Surh, L. Peltonen, O. Winqvist. 2006. Increased antigen presenting cell-mediated T cell activation in mice and patients without the autoimmune regulator. Eur. J. Immunol. 36: 305-317. [Medline]
39. Jonuleit, H., E. Schmitt, K. Steinbrink, A. H. Enk. 2001. Dendritic cells as a tool to induce anergic and regulatory T cells. Trends Immunol. 22: 394-400. [Medline]
40. Farr, A. G., J. L. Dooley, M. Erickson. 2002. Organization of thymic medullary epithelial heterogeneity: implications for mechanisms of epithelial differentiation. Immunol. Rev. 189: 20-27. [Medline]
41. Bouneaud, C., P. Kourilsky, P. Bousso. 2000. Impact of negative selection on the T cell repertoire reactive to a self-peptide: a large fraction of T cell clones escapes clonal deletion. Immunity 13: 829-840. [Medline]

This article has been cited by other articles:

				A. V. Misharin, Y. Nagayama, H. A. Aliesky, B. Rapoport, and S. M. McLachlan Studies in Mice Deficient for the Autoimmune Regulator (Aire) and Transgenic for the Thyrotropin Receptor Reveal a Role for Aire in Tolerance for Thyroid Autoantigens Endocrinology, June 1, 2009; 150(6): 2948 - 2956. [Abstract] [Full Text] [PDF]

				A. Meloni, M. Furcas, F. Cetani, C. Marcocci, A. Falorni, R. Perniola, M. Pura, A. S. Boe Wolff, E. S. Husebye, D. Lilic, et al. Autoantibodies against Type I Interferons as an Additional Diagnostic Criterion for Autoimmune Polyendocrine Syndrome Type I J. Clin. Endocrinol. Metab., November 1, 2008; 93(11): 4389 - 4397. [Abstract] [Full Text] [PDF]

				J. J. DeVoss, A. K. Shum, K. P. A. Johannes, W. Lu, A. K. Krawisz, P. Wang, T. Yang, N. P. LeClair, C. Austin, E. C. Strauss, et al. Effector Mechanisms of the Autoimmune Syndrome in the Murine Model of Autoimmune Polyglandular Syndrome Type 1 J. Immunol., September 15, 2008; 181(6): 4072 - 4079. [Abstract] [Full Text] [PDF]

				F.-X. Hubert, S. A. Kinkel, K. E. Webster, P. Cannon, P. E. Crewther, A. I. Proeitto, L. Wu, W. R. Heath, and H. S. Scott A Specific Anti-Aire Antibody Reveals Aire Expression Is Restricted to Medullary Thymic Epithelial Cells and Not Expressed in Periphery J. Immunol., March 15, 2008; 180(6): 3824 - 3832. [Abstract] [Full Text] [PDF]

				M. Alimohammadi, P. Bjorklund, A. Hallgren, N. Pontynen, G. Szinnai, N. Shikama, M. P. Keller, O. Ekwall, S. A. Kinkel, E. S. Husebye, et al. Autoimmune Polyendocrine Syndrome Type 1 and NALP5, a Parathyroid Autoantigen N. Engl. J. Med., March 6, 2008; 358(10): 1018 - 1028. [Abstract] [Full Text] [PDF]

				A. De Luca, C. Montagnoli, T. Zelante, P. Bonifazi, S. Bozza, S. Moretti, C. D'Angelo, C. Vacca, L. Boon, F. Bistoni, et al. Functional yet Balanced Reactivity to Candida albicans Requires TRIF, MyD88, and IDO-Dependent Inhibition of Rorc J. Immunol., November 1, 2007; 179(9): 5999 - 6008. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kekäläinen, E. Articles by Arstila, T. P. Search for Related Content PubMed PubMed Citation Articles by Kekäläinen, E. Articles by Arstila, T. P. Pubmed/NCBI databases Genetics Home Reference